Title: “Revolutionizing Cancer Treatment: The Chemistry and Business of Immunotherapy”

Term Paper – at least 2000 word paper (no exceptions and not including citations) on a topic covering a chemical or biology innovation with a focus on the discussion of the course. The student would then be required to research the innovation, the chemistry or biology behind it, and the commercial impact. No papers on Tesla Motors, 3D printers or cell phone/computer “Apps” will be accepted. . Papers must be submitted on D2L by this date or they will be considered late. The marks breakdown for the term paper is as follows: 40 % on the discussion of the science ( no laundry list of what the science does but
how it works.); 40 % on the discussion of the business case and: 20 % on how you put the two together